TCM
CDLX icon

Tybourne Capital Management’s Cardlytics CDLX Stock Holding History

Tybourne Capital Management’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-73,792
Closed -$51.6M – 30
2020
Q2 		$51.6M Buy
+73,792
New +$42.6M 1.57% 19

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Tybourne Capital Management's CDLX Position: Q3 2020 in Review

Tybourne Capital Management sold out of Cardlytics (CDLX) in Q3 2020, closing a stake of 73,792 shares — an estimated $51.6M sold.

Tybourne Capital Management first reported a position in CDLX in Q2 2020 and held it in 1 quarter. The position peaked at $51.6M in Q2 2020. 164 funds tracked by Wall St. Rank hold CDLX as of Q3 2020.

  • Tybourne Capital Management reported no remaining Cardlytics position as of Q3 2020 after selling out during the quarter.
  • Tybourne Capital Management sold 73,792 Cardlytics shares in Q3 2020, an estimated $51.6M.
  • Tybourne Capital Management first reported a position in Cardlytics in Q2 2020 and held it in 1 quarter.
  • Tybourne Capital Management's Cardlytics position peaked at $51.6M in Q2 2020.
  • 164 funds tracked by Wall St. Rank held Cardlytics as of Q3 2020.

Based on Tybourne Capital Management's 13F filing for Q3 2020, filed 9 Nov 2020.